Stay updated on Palovarotene for MO: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.

Latest updates to the Palovarotene for MO: Efficacy & Safety Clinical Trial page
- ChecktodayChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a new version of the study page content.SummaryDifference0.1%

- Check7 days agoChange DetectedThe collaborators section of the MO-Ped study page removes MHE Coalition from the list of partners. This update changes who is credited as a collaborator on the MO-Ped trial.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision indicator updated from v3.5.2 to v3.5.3, signaling a minor site update to the page. No study data or details are affected by this change.SummaryDifference0.1%

- Check30 days agoChange DetectedThe displayed revision version at the bottom of the page was updated from v3.5.0 to v3.5.2. No other study details appear to have changed.SummaryDifference0.0%

- Check37 days agoChange DetectedPublications and record history entries were added; core study details and locations remain unchanged.SummaryDifference0.1%

- Check44 days agoChange DetectedThe MO-Ped trial (NCT03442985) was terminated early to analyze accumulated data and evaluate the future of palovarotene in MO.SummaryDifference0.1%

Stay in the know with updates to Palovarotene for MO: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.